Drug information for MUCOSIL-10
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
SOLUTION; INHALATION, ORAL
10%
Discontinued
ACETYLCYSTEINE
Acetylcysteine
DEY
70575
Drug Adverse Effects information for MUCOSIL-10
Role code
Indications
Reaction
# Reports
C
ANAPLASTIC ASTROCYTOMA
ANAEMIA
1
C
ANAPLASTIC ASTROCYTOMA
CEREBRAL ATROPHY
1
C
ANAPLASTIC ASTROCYTOMA
DEVICE RELATED INFECTION
1
C
ANAPLASTIC ASTROCYTOMA
HYPOALBUMINAEMIA
1
C
ANAPLASTIC ASTROCYTOMA
OLIGURIA
1
C
ANAPLASTIC ASTROCYTOMA
OROPHARYNGEAL CANDIDIASIS
1
C
ANAPLASTIC ASTROCYTOMA
THROMBOCYTOPENIA
1
C
ASTHMA
DELIRIUM
1
C
ASTHMA
PYREXIA
1
C
ASTHMA
SLEEP TERROR
2
C
CANCER PAIN
WHITE BLOOD CELL COUNT DECREASED
1
C
CASTLEMAN'S DISEASE
BLOOD BILIRUBIN INCREASED
2
C
CASTLEMAN'S DISEASE
BLOOD PHOSPHORUS DECREASED
2
C
CASTLEMAN'S DISEASE
CONSTIPATION
2
C
CASTLEMAN'S DISEASE
DERMAL CYST
2
C
CASTLEMAN'S DISEASE
DIARRHOEA
2
C
CASTLEMAN'S DISEASE
HAEMATURIA
2
C
CASTLEMAN'S DISEASE
HERPES ZOSTER
2
C
CASTLEMAN'S DISEASE
HYPERURICAEMIA
2
C
CASTLEMAN'S DISEASE
LYMPHOCYTE MORPHOLOGY ABNORMAL
2
C
CASTLEMAN'S DISEASE
NEOPLASM OF ORBIT
2
C
CASTLEMAN'S DISEASE
NEUTROPHIL COUNT DECREASED
2
C
CASTLEMAN'S DISEASE
OEDEMA PERIPHERAL
2
C
CASTLEMAN'S DISEASE
PAIN IN EXTREMITY
2
C
CASTLEMAN'S DISEASE
PNEUMONIA
2
C
CASTLEMAN'S DISEASE
PROTEIN URINE PRESENT
2
C
CASTLEMAN'S DISEASE
RASH
2
C
CASTLEMAN'S DISEASE
STOMATITIS
2
C
CASTLEMAN'S DISEASE
UPPER RESPIRATORY TRACT INFLAMMATION
2
C
CEREBRAL ATROPHY
ANAEMIA
4
C
CEREBRAL ATROPHY
CEREBRAL ATROPHY
4
C
CEREBRAL ATROPHY
DEVICE RELATED INFECTION
4
C
CEREBRAL ATROPHY
HYPOALBUMINAEMIA
4
C
CEREBRAL ATROPHY
OLIGURIA
4
C
CEREBRAL ATROPHY
OROPHARYNGEAL CANDIDIASIS
4
C
CEREBRAL ATROPHY
THROMBOCYTOPENIA
4
C
COLORECTAL CANCER
HEPATIC FUNCTION ABNORMAL
1
C
EPILEPSY
HYPOKALAEMIA
2
C
INFLUENZA
DELIRIUM
2
C
INFLUENZA
SLEEP TERROR
2
C
LUNG NEOPLASM MALIGNANT
AGRANULOCYTOSIS
1
C
LUNG NEOPLASM MALIGNANT
OROPHARYNGEAL PAIN
1
C
LUNG NEOPLASM MALIGNANT
PYREXIA
1
C
LUNG NEOPLASM MALIGNANT
SEPSIS
1
C
MUSCLE SPASTICITY
IMPLANT SITE EFFUSION
1
C
MUSCLE SPASTICITY
IMPLANT SITE OEDEMA
1
C
NEURALGIA
COGNITIVE DISORDER
3
C
NEURALGIA
MALAISE
3
C
NEURALGIA
SPEECH DISORDER
3
C
PNEUMONIA
AGRANULOCYTOSIS
2
C
PNEUMONIA
OROPHARYNGEAL PAIN
2
C
PNEUMONIA
PYREXIA
2
C
PNEUMONIA
SEPSIS
2
C
PREGNANCY
ASTHMA
8
C
PREGNANCY
CAESAREAN SECTION
8
C
PREGNANCY
CEREBRAL VENTRICLE DILATATION
8
C
PREGNANCY
HYDROCEPHALUS
8
C
PREGNANCY
LOW BIRTH WEIGHT BABY
8
C
PREGNANCY
MENINGOCELE
8
C
PREGNANCY
PATERNAL DRUGS AFFECTING FOETUS
8
C
PRODUCT USED FOR UNKNOWN INDICATION
AGRANULOCYTOSIS
2
C
PRODUCT USED FOR UNKNOWN INDICATION
OROPHARYNGEAL PAIN
2
C
PRODUCT USED FOR UNKNOWN INDICATION
PYREXIA
2
C
PRODUCT USED FOR UNKNOWN INDICATION
SEPSIS
2
C
PRODUCT USED FOR UNKNOWN INDICATION
WHITE BLOOD CELL COUNT DECREASED
1
C
RENAL FAILURE
AGRANULOCYTOSIS
2
C
RENAL FAILURE
OROPHARYNGEAL PAIN
2
C
RENAL FAILURE
PYREXIA
2
C
RENAL FAILURE
SEPSIS
2
Ads by Google